{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T18:50:28Z","timestamp":1779130228766,"version":"3.51.4"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004434","name":"Universit\u00e0 degli Studi di Firenze","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masarykova Univerzita","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.bioorg.2020.104565","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T23:09:17Z","timestamp":1608332957000},"page":"104565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prediction of biological activity of compounds containing a 1,3,5-triazinyl sulfonamide scaffold by artificial neural networks using simple molecular descriptors"],"prefix":"10.1016","volume":"107","author":[{"given":"Eva","family":"Havr\u00e1nkov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.M.","family":"Pe\u00f1a-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Cs\u00f6llei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Havel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104565_b0005","unstructured":"Cancer: Fact sheet, 2019. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer (accessed May 15, 2019)."},{"key":"10.1016\/j.bioorg.2020.104565_b0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jab.2015.03.003","article-title":"Coordination compounds in cancer: Past, present and perspectives","volume":"13","author":"Trudu","year":"2015","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.bioorg.2020.104565_b0015","series-title":"The Cell: A Molecular Approach","author":"Cooper","year":"1996"},{"key":"10.1016\/j.bioorg.2020.104565_b0020","doi-asserted-by":"crossref","first-page":"R608","DOI":"10.1152\/ajpregu.00538.2003","article-title":"HIFs and tumors\u2014causes and consequences","volume":"286","author":"H\u00f6pfl","year":"2004","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bioorg.2020.104565_b0025","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Sherwood","year":"1971","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2020.104565_b0030","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1128\/MCB.24.7.2875-2889.2004","article-title":"Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance","volume":"24","author":"Erler","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bioorg.2020.104565_b0035","series-title":"Carbonic Anhydrase-Its Inhibitors and Activators","first-page":"253","article-title":"Cancer-related carbonic anhydrase isozymes","author":"Pastorekova","year":"2004"},{"key":"10.1016\/j.bioorg.2020.104565_b0040","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/14756360410001689540","article-title":"Carbonic anhydrases: current state of the art, therapeutic applications and future prospects","volume":"19","author":"Pastorekova","year":"2008","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"\u0160vastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2020.104565_b0050","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104565_b0055","first-page":"e409272","article-title":"The role of hypoxia inducible factor-1 in hepatocellular carcinoma","volume":"2014","author":"Luo","year":"2014","journal-title":"Bio. Med Res. Int."},{"key":"10.1016\/j.bioorg.2020.104565_b0060","doi-asserted-by":"crossref","first-page":"6160","DOI":"10.1158\/0008-5472.CAN-03-2224","article-title":"Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion","volume":"64","author":"Robertson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2020.104565_b0065","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.3390\/molecules20022323","article-title":"Targeting carbonic anhydrase IX activity and expression","volume":"20","author":"Mahon","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2020.104565_b0070","doi-asserted-by":"crossref","unstructured":"M. Benej, S. Pastorekova, J. Pastorek, J. Carbonic Anhydrase IX: Regulation and Role in Cancer, in: S.C. Frost, R. McKenna, (Eds.) Carbonic Anhydrase: Mechanism, Regulation, Links to Disease, and Industrial Applications, Subcellular Biochemistry: Springer, Netherlands, 2014, pp. 199\u2013219.","DOI":"10.1007\/978-94-007-7359-2_11"},{"key":"10.1016\/j.bioorg.2020.104565_b0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/metabo7030048","article-title":"Carbonic anhydrase inhibition and the management of hypoxic tumors","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2020.104565_b0080","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.bioorg.2020.104565_b0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metast. Rev."},{"key":"10.1016\/j.bioorg.2020.104565_b0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bioorg.2020.104565_b0095","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1016\/j.bmcl.2004.07.087","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic\/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties","volume":"14","author":"Garaj","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104565_b0100","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1016\/j.bmcl.2005.04.056","article-title":"Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX","volume":"15","author":"Garaj","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104565_b0105","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.bmcl.2014.01.048","article-title":"Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII","volume":"24","author":"Saluja","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104565_b0110","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1016\/j.bmc.2011.04.005","article-title":"Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: solution and X-ray crystallographic studies","volume":"19","author":"Carta","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bioorg.2018.08.005","article-title":"Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX","volume":"81","author":"Miku\u0161","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bioorg.2017.12.034","article-title":"Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action","volume":"77","author":"Havr\u00e1nkov\u00e1","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104565_b0130","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4155\/fmc.15.71","article-title":"Carbonic anhydrase IX inhibitors in cancer therapy: an update","volume":"7","author":"Supuran","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0135","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.molstruc.2018.02.107","article-title":"Development of selective QSAR models and molecular docking study for inhibitory activity of sulfonamide derivatives against carbonic anhydrase isoforms II and IX","volume":"1163","author":"Yorulmaz","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2020.104565_b0140","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1016\/j.bmcl.2004.03.099","article-title":"Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides","volume":"14","author":"Jaiswal","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104565_b0145","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jmgm.2007.03.015","article-title":"A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II","volume":"26","author":"Eroglu","year":"2007","journal-title":"J. Mol. Grap. Model."},{"key":"10.1016\/j.bioorg.2020.104565_b0150","first-page":"1","article-title":"Sulfonamide based \u03b2 -carbonic anhydrase Inhibitors: 2d QSAR study","volume":"2013","author":"Deodhar","year":"2013","journal-title":"ISRN Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0155","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bmc.2005.09.038","article-title":"QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices","volume":"14","author":"Melagraki","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/i8020145","article-title":"A DFT-based QSARs study of acetazolamide\/sulfanilamide derivatives with carbonic anhydrase (CA-II) isozyme inhibitory activity","volume":"8","author":"Ero\u011flu","year":"2007","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104565_b0165","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00044-009-9262-0","article-title":"QSAR analysis of some novel sulfonamides incorporating 1,3,5-triazine derivatives as carbonic anhydrase inhibitors","volume":"19","author":"Jain","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104565_b0170","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/157340612801216391","article-title":"A QSAR study on novel series of carbonic anhydrase inhibitors hCA IX\u2014tumor-associated (hypoxia)","volume":"8","author":"Singh","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0175","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.2174\/156802612804910278","article-title":"A survey of quantitative descriptions of molecular structure","volume":"12","author":"Guha","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0180","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/ci0500177","article-title":"A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication","volume":"45","author":"Bender","year":"2005","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2020.104565_b0185","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.talanta.2006.05.054","article-title":"Structure\u2013activity correlations for illicit amphetamines using ANN and constitutional descriptors","volume":"70","author":"Gosav","year":"2006","journal-title":"Talanta"},{"key":"10.1016\/j.bioorg.2020.104565_b0190","series-title":"Computational Drug Design: A Guide for Computational and Medicinal Chemists","author":"Young","year":"2009"},{"key":"10.1016\/j.bioorg.2020.104565_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5012\/jkcs.2016.60.4.225","article-title":"A DFT and QSAR study of several sulfonamide derivatives in gas and solvent","volume":"60","author":"kord Abadi","year":"2016","journal-title":"J. Korean Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.104565_b0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.22159\/ijpps.2018v10i1.22775","article-title":"Modeling of carbonic anhydrase (Ii) inhibitory activities of sulphonilamide schiff bases by artificial neural network trained with different numerical techniques","volume":"10","author":"Pandey","year":"2018","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2020.104565_b0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1134\/S106816201306006X","article-title":"Comparison of QSAR models based on combinations of genetic algorithm, stepwise multiple linear regression, and artificial neural network methods to predict Kd of some derivatives of aromatic sulfonamides as carbonic anhydrase II inhibitors","volume":"40","author":"Maleki","year":"2014","journal-title":"Russ. J. Bioorgan. Chem."},{"key":"10.1016\/j.bioorg.2020.104565_b0210","doi-asserted-by":"crossref","unstructured":"H. Chauhan, J. Bernick, D. Prasad, V. Masand, The role of artificial neural networks on target validation in drug discovery and development, in: M. Puri, Y. Pathak, V.K. Sutariya, S. Tipparaju, W. Moreno (Eds.), Artificial Neural Network For Drug Design, Delivery And Disposition, Academic Press, USA, 2016, pp. 15\u201327. https:\/\/doi.org\/10.1016\/B978-0-12-801559-9.00002-8.","DOI":"10.1016\/B978-0-12-801559-9.00002-8"},{"key":"10.1016\/j.bioorg.2020.104565_b0215","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.talanta.2013.04.031","article-title":"Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks","volume":"115","author":"Pivetta","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.bioorg.2020.104565_b0220","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3390\/ijms21103661","article-title":"Synthetic strategies and computational inhibition activity study for triazinyl-substituted benzenesulfonamide conjugates with polar and hydrophobic amino acids as inhibitors of carbonic anhydrases","volume":"21","author":"Mikulov\u00e1","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104565_b0225","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0731-7085(99)00272-1","article-title":"Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research","volume":"22","author":"Agatonovic-Kustrin","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.bioorg.2020.104565_b0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/qsar.19960150103","article-title":"Using artificial neural networks to predict biological activity from simple molecular structural considerations","volume":"15","author":"Burden","year":"1996","journal-title":"Quant. Struct.-Act. Relat."},{"key":"10.1016\/j.bioorg.2020.104565_b0235","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2478\/v10136-012-0031-x","article-title":"Artificial neural networks in medical diagnosis","volume":"11","author":"Amato","year":"2013","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.bioorg.2020.104565_b0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1573409911309010012","article-title":"Artificial neural networks based on CODES descriptors in pharmacology: identification of novel trypanocidal drugs against chagas disease","volume":"9","author":"Guerra","year":"2013","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.bioorg.2020.104565_b0245","doi-asserted-by":"crossref","unstructured":"A. Ion, S. Gosav, M. Praisler, Screening for NBOMe hallucinogens based on artificial neural networks and structural descriptors, in: 2019 E-Health and Bioengineering Conference (EHB), Iasi, Romania, 2019, pp. 1\u20134. https:\/\/doi.org\/10.1109\/EHB47216.2019.8970048.","DOI":"10.1109\/EHB47216.2019.8970048"},{"key":"10.1016\/j.bioorg.2020.104565_b0250","first-page":"347","article-title":"A simple approach for assessment of toxicity of nitroaromatic compounds without using complex descriptors and computer codes, SAR and QSAR","volume":"30","author":"Keshavarz","year":"2019","journal-title":"Environ. Res."},{"key":"10.1016\/j.bioorg.2020.104565_b0255","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1021\/acs.iecr.5b01457","article-title":"Mixture descriptors toward the development of quantitative structure-property relationship models for the flash points of organic mixtures","volume":"54","author":"Gaudin","year":"2015","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.bioorg.2020.104565_b0260","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1016\/j.ygeno.2020.03.020","article-title":"Molib: A machine learning based classification tool for the prediction of biofilm inhibitory molecules","volume":"112","author":"Srivastava","year":"2020","journal-title":"Genomics"},{"key":"10.1016\/j.bioorg.2020.104565_b0265","article-title":"Prediction of the toxicity of binary mixtures by QSAR approach using the hypothetical descriptors","volume":"19","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2020.104565_b0270","unstructured":"ACD\/ChemSketch 2015 Pack2 (File Version C20H41, Build 78694, 08 Jun 2015) from ACD\/Labs, Copyright@1994-2015, Advanced Chemistry Development, Inc."},{"key":"10.1016\/j.bioorg.2020.104565_b0275","unstructured":"Trajan 4.0 software package, Trajan Software, Trajan neural network simulator, Release 4.0 D. Durham, UK: Trajan Software Ltd., 1999."},{"key":"10.1016\/j.bioorg.2020.104565_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24193586","article-title":"New approach for the one-pot synthesis of 1,3,5-triazine derivatives: application of Cu(I) supported on a weakly acidic cation-exchanger resin in a comparative study","volume":"24","author":"Havr\u00e1nkov\u00e1","year":"2019","journal-title":"Molecules"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:11:13Z","timestamp":1758615073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820318630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":56,"alternative-id":["S0045206820318630"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104565","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of biological activity of compounds containing a 1,3,5-triazinyl sulfonamide scaffold by artificial neural networks using simple molecular descriptors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104565","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104565"}}